EUR 0.4
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -148 Thousand | - | -59 Thousand | -97 Thousand | -463 Thousand | -387 Thousand |
Net Income | -220 Thousand | -216 Thousand | -50 Thousand | -141 Thousand | -220 Thousand | -659 Thousand |
Depreciation & Amortization | - | - | - | - | - | 13 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 90 Thousand | - | -9000.00 | 41 Thousand | -230 Thousand | 150 Thousand |
Other non-cash items | -108 Thousand | 216 Thousand | -28 Thousand | 3000.00 | -13 Thousand | 109 Thousand |
Investing Cash Flow | - | - | -90 Thousand | 3000.00 | 3.00 | 3000.00 |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | -21 Thousand | -21.00 | -21 Thousand |
Investment purchases | - | - | - | - | - | -21 Thousand |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -90 Thousand | 24 Thousand | 24.00 | 24 Thousand |
Financing Cash Flow | 149 Thousand | - | 80 Thousand | - | 214 Thousand | 196 Thousand |
Debt repayment | -149 Thousand | - | -80 Thousand | - | -86 Thousand | -338 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 300 Thousand | 414 Thousand |
Other Financing Activities | -18 Thousand | - | 160 Thousand | - | 214.00 | 120 Thousand |
Accounts receivables | 90 Thousand | - | -9000.00 | - | -102 Thousand | 131 Thousand |
Accounts payables | - | - | 37 Thousand | 41 Thousand | -128 Thousand | 19 Thousand |
Inventory | - | - | - | - | 128.00 | - |
Other working capital | 90 Thousand | - | -37 Thousand | 41.00 | -128.00 | 19 Thousand |
Cash at beginning of period | 77 Thousand | 77 Thousand | 118 Thousand | 215 Thousand | 464 Thousand | 652 Thousand |
Cash at end of period | 1000.00 | 77 Thousand | 77 Thousand | 118 Thousand | 215 Thousand | 464 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | 28 Thousand | - | -3.00 | - |
Net cash flow / Change in cash | -76 Thousand | - | -41 Thousand | -97 Thousand | -249 Thousand | -188 Thousand |
Free Cash Flow | -148 Thousand | - | -59 Thousand | -97 Thousand | -463 Thousand | -387 Thousand |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -220 Thousand | -46.50 | -46.50 | -63.50 | -63.50 | -216 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 90 Thousand | - | - | - | - | - |
Other non-cash items | -108 Thousand | 46.50 | 46.50 | 63.50 | 63.50 | 216 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 149 Thousand | - | - | - | - | - |
Debt repayment | -149 Thousand | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -18 Thousand | - | - | - | - | - |
Accounts receivables | 90 Thousand | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 90 Thousand | - | - | - | - | - |
Cash at beginning of period | 77 Thousand | - | - | 25 Thousand | - | 77 Thousand |
Cash at end of period | 1000.00 | - | - | 5000.00 | - | 77 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -76 Thousand | - | - | -20 Thousand | - | - |
Free Cash Flow | -148 Thousand | - | - | - | - | - |
000791
PVSL
MOSHI
SPIDY
IVCA
PTRUF